Q2 26 EPS
$0.19
BEAT +230.43%
Est. $0.06
Q2 26 Revenue
$508.0M
BEAT +5.35%
Est. $482.2M
vs S&P Since Q2 26
-4.7%
TRAILING MARKET
MBLY -0.2% vs S&P +4.5%
Market Reaction
Did MBLY Beat Earnings? Q2 2026 Results
Mobileye Global delivered a striking second-quarter earnings beat on Wednesday, posting adjusted diluted EPS of $0.19 against a consensus estimate of negative $0.04, a 575.00% positive surprise that extended the company's streak of beating consensus … Read more Mobileye Global delivered a striking second-quarter earnings beat on Wednesday, posting adjusted diluted EPS of $0.19 against a consensus estimate of negative $0.04, a 575.00% positive surprise that extended the company's streak of beating consensus EPS estimates to five consecutive quarters. Revenue came in at $508.00 million, essentially flat year-over-year at +0.4%, as a 3% rise in system shipments to 10.0 million units was nearly offset by declining average selling prices tied to higher China OEM export volumes. The headline earnings story, however, was largely shaped by a one-time catch-up from Israel's newly enacted R&D Law incentive grant, which applied retroactively from the start of 2026 and contributed roughly $93.00 million in non-GAAP R&D expense offsets during the quarter alone. That benefit drove adjusted operating income up 46% to $155.00 million, even as GAAP gross margin contracted 354 basis points to 46%. Looking ahead, Mobileye raised its full-year 2026 revenue guidance to $1.97 billion to $2.02 billion and lifted adjusted operating income guidance to $365.00 million to $425.00 million, an 88% increase at midpoint from prior guidance, given that the R&D Law benefit carries no scheduled expiration. Options markets had anticipated roughly a 9% stock move around the release.
Key Takeaways
- • 3% increase in system shipment volumes from higher customer demand
- • R&D Law incentive grant of ~$110M GAAP recognized in Q2 covering H1 2026
- • Lower EyeQ ASP due to higher China OEM export volumes with lower pricing
- • Higher SuperVision revenue mix with lower margin due to greater hardware content
MBLY Forward Guidance & Outlook
Mobileye raised full-year 2026 revenue guidance to $1,970–$2,020 million (up $20 million at midpoint), implying 4%–7% year-over-year growth. Full-year GAAP operating loss guidance narrowed to $(4,154)–$(4,094) million. Adjusted operating income guidance was raised significantly to $365–$425 million, an 88% increase at midpoint from prior guidance of $185–$235 million, primarily due to the Israeli R&D Law incentive grant enacted in Q2 which applies from the beginning of 2026 and has no scheduled expiration. The R&D Law benefit incorporated into full-year guidance is $197–$217 million (GAAP) and $180–$200 million (non-GAAP). The company expects multiple advanced product launches in late 2026 and throughout 2027.
MBLY YoY Financials
Q2 2026 vs Q2 2025, source: SEC Filings
MBLY Revenue by Segment
With YoY comparisons, source: SEC Filings
“The core business continued its strong momentum in Q2 as we focus our development and execution efforts on a number of advanced product launches in late 2026 and throughout 2027.”
— Amnon Shashua, Q2 2026 Earnings Press Release
MBLY Earnings Trends
MBLY vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
MBLY EPS Trend
Earnings per share: estimate vs actual
MBLY Revenue Trend
Quarterly revenue: estimate vs actual
MBLY Quarterly Results
6 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q2 26 BEAT | $0.06 | $0.19 | +230.43% | $508.0M | +5.35% |
| Q1 26 BEAT | $0.09 | $0.12 | +38.41% | $558.0M | +7.40% |
| Q4 25 BEAT FY | $0.06 | $0.06 | +3.27% | $446.0M | +3.28% |
| FY Full Year | $0.36 | — | — | $1.89B | +0.86% |
| Q3 25 BEAT | $0.09 | $0.09 | +3.57% | $504.0M | +3.91% |
| Q2 25 BEAT | $0.11 | $0.13 | +21.61% | $506.0M | +2.03% |
| Q1 25 BEAT | $0.08 | $0.08 | +5.68% | $438.0M | +0.60% |